Abstract
Objective
To examine the prevalence of use, abuse, and dependence on legal and illegal psychotropic substances in an adolescent in-patient psychiatric population in relation to age and gender.
Methods
Participants were all consecutive admissions (patients aged from 14 to 17) to the adolescent psychiatric in-patient unit. Of the 86 patients who met all the criteria for taking part in the study 70 were interviewed, giving a response rate of 81%. Prevalence of use and of substance use disorders were assessed through structured diagnostic interviews (M-CIDI), conducted from March 2000 through July 2000.
Results
We found high prevalence of use and of the diagnosis of legal and illegal psychotropic substances. Around 76% reported a regular use of tobacco, 44% regular alcohol use, and 40% regular use of illegal substances. Diagnosis (abuse or dependence) was found in 50% of cases for nicotine, 29% for alcohol, and 26% for illegal substances.
Conclusions
The adolescent in-patient psychiatric population is at high risk of use, abuse, and dependence on legal and illegal psychotropic substances. It is important to diagnose these disorders (anamnesis, screening tools) and to install preventive and therapeutic programs in clinical therapeutic settings.
Similar content being viewed by others
References
Bundeszentrale für gesundheitliche Aufklärung (Federal Centre for Health Education) (1994, 1997, 2001, 2004). Die Drogenaffinität Jugendlicher in der BRD
Chen K, Kandel DB (1995) The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am J Public Health 85:41–47
Deas-Nesmith D, Campbell S, Brady KT (1998) Substance use disorders in an adolescent inpatient psychiatric population. J Natl Med Assoc 90:233–238
Fulkerson JA, Harrison PA, Beebe TJ (1999) DSM-IV substance abuse and dependence: are there really two dimensions of substance use disorders in adolescents? Addiction 94:495–506
Hansen SS, Munk-Jorgensen P, Guldbaek B, Solgard T, Lauszus KS, Albrechtsen N, Borg L, Egander A, Faurholdt K, Gilberg A, Godsen NP, Lorenzen J, Richelsen B, Weischer K, Bertelsen A (2000) Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand 102:432–438
Kandel DB, Johnson JG, Bird H, Weissman MM, Goodman SH, Lahey BB, Regier DA, Schwab-Stone ME (1999) Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA study. J Am Acad Child Adolesc Psychiatry 38:693–699
Kandel DB, Yamaguchi K, Chen K (1992) Stages of progression in drug involvment from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 53:447–457
Kessler RC, McGonagle KA, Zhao S, Nelson C, Hughes M, Eshleman S, Wittchen H-U, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19
Lachner G, Wittchen H-U, Perkonigg A, Holly A, Schuster P, Wunderlich U, Türk D, Garczynski E, Pfister H (1998) Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI). Substance use sections. Eur Addict Res 4:28–41
Lieb R, Schuster P, Pfister H, Fuetsch M, Höfler M, Isensee B, Müller N, Sonntag H, Wittchen H-U (2000) Epidemiologie des Konsums, Missbrauch und der Abhängigkeit von legalen und illegalen Drogen bei Jugendlichen und jungen Erwachsenen: die prospektiv-longitudinale Verlaufstudie EDSP. Sucht 46:18–31
Nelson CB, Wittchen H-U (1998) DSM-IV alcohol disorders in a general population sample of adolescents and young adults. Addiction 93:1065–1077
Nelson CB, Wittchen H-U (1998) The EDSP: setting the stage! Eur Addict Res 4:5–7
Nelson CB, Wittchen H-U (1998) Smoking and nicotine dependence. Eur Addict Res 4:42–49
Perkonigg A, Lieb R, Wittchen H-U (1998) Substance use, abuse and dependence in Germany. A review of selected epidemiological data. Eur Addict Res 4:8–17
Perkonigg A, Lieb R, Wittchen H-U (1998) Prevalence of use, abuse and dependence of illicit drugs among adolescents and young adults in a community sample. Eur Addict Res 4:58–66
Reed V, Gander F, Pfister H, Steiger A, Sonntag H, Trenkwalder C, Sonntag A, Hundt W, Wittchen H-U (1998) To what degree does the Composite International Diagnostic Interview (CIDI) correctly identifies DSM-IV disorders? Testing validity issues in a clinical sample. Int J Methods Psychiatr Res 7:142–155
Warner LA, Kessler RC, Hughes M, Anthony J, Nelson C (1995) Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 52:219–229
Wittchen H-U et al. (1998) Test–retest reliability of the computerized DSM-IV version of the Munich Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33:568–578
Wittchen H-U (1994) Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 28:57–84
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niethammer, O., Frank, R. Prevalence of use, abuse and dependence on legal and illegal psychotropic substances in an adolescent inpatient psychiatric population. Eur Child Adolesc Psychiatry 16, 254–259 (2007). https://doi.org/10.1007/s00787-006-0597-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00787-006-0597-5